Please use this identifier to cite or link to this item:
|Title:||B-type natriuretic peptide: Issues for the intensivist and pulmonologist|
|Keywords:||B-type natriuretic peptide|
N-terminal pro-B-type natriuretic peptide
|Citation:||Jason, P., Keang, L.T., Hoe, L.K. (2005-09). B-type natriuretic peptide: Issues for the intensivist and pulmonologist. Critical Care Medicine 33 (9) : 2094-2103. ScholarBank@NUS Repository. https://doi.org/10.1097/01.CCM.0000178351.03327.9F|
|Abstract:||Objective: B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP), although promising as biomarkers for heart failure, are affected by multiple confounders. The purpose of this article is to review the literature on the utility of BNP and NT-proBNP as biomarkers, with a focus on their role in critical illness and pulmonary diseases. Data Source: Published articles on BNP and NT-proBNP. Data Analysis: Multiple disorders in the intensive care unit cause elevated BNP and NT-proBNP levels, including cardiac diseases, shock, pulmonary hypertension, acute respiratory distress syndrome, acute pulmonary embolism, chronic obstructive pulmonary disease, renal failure, and other conditions. Conclusions: Intensivists and pulmonologists should understand that BNP and NT-proBNP levels might be raised to different degrees not only in heart failure but also in critical illness and various pulmonary diseases; in these situations, BNP and NT-proBNP may also serve as markers of severity and prognosis. Copyright © 2005 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins.|
|Source Title:||Critical Care Medicine|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Nov 14, 2018
WEB OF SCIENCETM
checked on Oct 30, 2018
checked on Nov 15, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.